Primary and Salvage Laser Surgery of 341 Glottic Cancers-Comparison of Treatment Outcomes Between University Head Neck Tertiary Referral Center and Local Head Neck Department

被引:6
|
作者
Winiarski, Piotr [1 ]
Lewandowski, Artur [1 ]
Greczka, Grazyna [2 ]
Banaszewski, Jacek [2 ]
Klimza, Hanna [2 ]
Wierzbicka, Malgorzata [2 ]
机构
[1] Jan Biziel Second Univ Hosp, Dept Otolaryngol Otolaryngol Oncol & Maxillofacia, Bydgoszcz, Poland
[2] Poznan Univ Med Sci, Dept Otolaryngol & Oncol Laryngol, Poznan, Poland
关键词
larynx; laryngeal cancer; glottis cancer; early glottic carcinomas; glottis; laser; transoral laser microsurgery; transoral laser microlaryngoscopy; TLM; cordectomy; SQUAMOUS-CELL CARCINOMA; LARYNGEAL-CANCER; CO2-LASER SURGERY; RETROSPECTIVE ANALYSIS; ANTERIOR COMMISSURE; LEARNING-CURVE; MICROSURGERY; RADIOTHERAPY; POPULATION; CORDECTOMY;
D O I
10.1002/lsm.22759
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective: The main goal was to compare the clinical data of patients with T1 and T2 glottic cancer treated with CO2 transoral laser microlaryngoscopy (TLM) in the Tertiary Referral University Department of Otolaryngology, Head Neck Surgery, Poznan and the local Department of Otolaryngology, Oncology and Maxillofacial Surgery, Bydgoszcz. Material and Methods: Unified databases for the 7-year period January 2005-December 2011 were created to compare these two cohorts. The database contained 341 patients: 231 from the tertiary center and 110 from the local department, of which 298 (87%) were men, and 43 (13%) were women. Results: Cordectomy type I-IV was performed in 250 (73%) patients, cordectomy type V-VI in 84 (25%) patients, and cordectomy enlarged to epiglottic petiole in 7 (2%) patients. Local recurrence was observed in 96 (28%) cases. Among these cases, 81 (87.5%) patients had salvage surgery: 43 re-cordectomy, 10 open partial laryngectomy, and 28 total laryngectomy. The outcomes for the whole cohort, Tertiary Referral Center and Local Department respectively were as follows: larynx preservation rate was 91.8%, 93.6%, and 88%; 3-year disease specific survival was 97.4%, 97.9%, and 93.3%; 3-year overall survival was 93.5%, 96.6%, and 85.5%; 5-year disease specific survival was 95.2%, 95.2%, and 96.3%; and 5-year overall survival was 84.5%, 88.7%, and 76%, respectively. Conclusion: Comparison of the cohorts showed that outcomes of primary treatment were similar but there were noticeable differences in salvage treatment efficacy, favoring patients fromthe Tertiary Referral Center. Lasers Surg. Med. 50: 311-318, 2018. (c) 2017Wiley Periodicals, Inc.
引用
收藏
页码:311 / 318
页数:8
相关论文
共 13 条
  • [1] Referral pattern for neoadjuvant chemotherapy in the head and neck cancers in a tertiary care center
    Patil, V. M.
    Noronha, V
    Joshi, A.
    Krishna, V. M.
    Dhumal, S.
    Chaudhary, V
    Juvekar, S.
    Pai, P. S.
    Pankaj, C.
    Chaukar, D.
    Dcruz, A. K.
    Prabhash, K.
    INDIAN JOURNAL OF CANCER, 2014, 51 (02) : 100 - 103
  • [2] Outcomes with optimal treatment in geriatric head and neck cancers - Tertiary cancer centre experience
    Ahmed, Imtiaz
    Krishnamurthy, Sapna
    Bhise, Rohan
    Vinchurkar, Kumar
    Kalloli, Mahesh
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (05) : 1384 - 1389
  • [3] Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience
    Titaporn Nopmaneepaisarn
    Napadon Tangjaturonrasme
    Worawat Rawangban
    Chanida Vinayanuwattikun
    Somboon Keelawat
    Andrey Bychkov
    BMC Cancer, 19
  • [4] Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience
    Nopmaneepaisarn, Titaporn
    Tangjaturonrasme, Napadon
    Rawangban, Worawat
    Vinayanuwattikun, Chanida
    Keelawat, Somboon
    Bychkov, Andrey
    BMC CANCER, 2019, 19 (01)
  • [5] No impact of time to treatment initiation for head and neck cancer in a tertiary university center in 2003, 2008 and 2013
    Kouka, Mussab
    Engelhardt, Max
    Wittig, Andrea
    Schultze-Mosgau, Stefan
    Ernst, Thomas
    Guntinas-Lichius, Orlando
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (09) : 4549 - 4560
  • [6] Quality of life following treatment for T1a glottic cancer with surgery or radiotherapy: outcomes from the Head and Neck 5000 cohort
    O'Hara, James
    Whitmarsh, Alex
    Pring, Miranda
    Thomas, Steve
    Ness, Andy
    CLINICAL OTOLARYNGOLOGY, 2022, 47 (01) : 67 - 74
  • [7] A Prospective Randomised Study of Comparison between Conventional and Accelerated Fractionation Radiotherapy in Treatment of Head and Neck Cancers
    Hemanth, M.
    Subramanian, B., V
    Das, Pranabandhu
    Swapna, J.
    Lakshmi, A. Y.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (05) : XC05 - XC09
  • [8] Role of indocyanine green combined with radiotracer-Technetium 99 m in neck surgery for primary and recurrent head and neck cancer: preliminary results of a tertiary cancer center
    Suslu, Nilda Sutay
    Katar, Oguzhan
    Tuncel, Murat
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (03) : 1549 - 1560
  • [9] Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience
    Franco, Rejane
    de Matos, Leandro Luongo
    Vamondes Kulcsar, Marco Aurelio
    de Castro-Junior, Gilberto
    Marta, Gustavo Nader
    CLINICS, 2020, 75 : 1 - 8
  • [10] Oncological and functional outcomes for transoral robotic surgery following previous radiation treatment for upper aerodigestive tract head and neck cancers. A French multicenter GETTEC group study
    Malard, Olivier
    Karakachoff, Matilde
    Ferron, Christophe
    Hans, Stephane
    Vergez, Sebastien
    Garrel, Renaud
    Gorphe, Philippe
    Ramin, Lionel
    Santini, Laure
    Villeneuve, Alexandre
    Lasne-Cardon, Audrey
    Espitalier, Florent
    Hounkpatin, Audrey
    CANCER MEDICINE, 2024, 13 (07):